Designing herpes viruses as oncolytics ‌ Cole Peters, Samuel D Rabkin

Ստացեք ամբողջական տեքստը

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells ‌ Kimia Kardani, Judit Sanchez Gil, Samuel D. Rabkin

Ստացեք ամբողջական տեքստը

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma ‌ Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

Ստացեք ամբողջական տեքստը

Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade ‌ Praveen K. Bommareddy, Samuel D. Rabkin, Howard L. Kaufman

Ստացեք ամբողջական տեքստը

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma ‌ Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

Ստացեք ամբողջական տեքստը

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV ‌ Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza, Samuel D. Rabkin

Ստացեք ամբողջական տեքստը

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma ‌ Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman

Ստացեք ամբողջական տեքստը

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival ‌ Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto

Ստացեք ամբողջական տեքստը

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? ‌ Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

Ստացեք ամբողջական տեքստը

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer ‌ Timothy J. Jorgensen, Sanford Katz, Ellen K. Wittmack, Susan Varghese, Tomoki Todo, Samuel D. Rabkin, Robert L. Martuza

Ստացեք ամբողջական տեքստը

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells ‌ Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza

Ստացեք ամբողջական տեքստը

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models ‌ Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza

Ստացեք ամբողջական տեքստը

Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma ‌ Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L. Martuza, Hiroaki Wakimoto, Samuel D. Rabkin

Ստացեք ամբողջական տեքստը

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma ‌ Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin, Hiroaki Wakimoto

Ստացեք ամբողջական տեքստը

An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma ‌ Esther Rheinbay, Mario L. Suvà, Shawn M. Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, Andrew S. Chi, Bradley E. Bernstein

Ստացեք ամբողջական տեքստը

A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS) ‌ Ming-Ru Wu, Lior Nissim, Doron Stupp, Erez Pery, Adina Binder-Nissim, Karen Weisinger, Casper Enghuus, Sebastian R. Palacios, Melissa Humphrey, Zhizhuo Zhang, Eva Maria Novoa, Manolis Kellis, Ron Weiss, Samuel D. Rabkin, Yuval Tabach, Timothy K. Lu

Ստացեք ամբողջական տեքստը